BioMed Research International

Research Article

Diagnostic Value of Soluble Form of Mer Tyrosine Kinase (sMerTK) in Tuberculous Pleural Effusion and Malignant Pleural Effusion

Table 1

Demographic data of PE patients.
TPE ()MPE () value
Age (years)
Sex ()M: 36 (56.3%)M: 40 (55.6%)#
F: 28 (43.7%)F: 32 (44.4%)
ADA (U/L)
LDH (U/L)
LDH pleural/serum ratio>0.6>0.6
CEA in PE (ng/ml)
Protein (g/L)
Leukocyte count (106/L)
Lymphocyte (%)88.00 (75.5–93.5)76.5 (61.75–90.0)
Neutrophil (%)5 (1–12.75)7 (1.5–12)
Protein pleural/serum ratio> 0.5> 0.5#
sMerTK
IL-1β (pg/ml)
TNF-α (pg/ml)
TPE: tuberculous pleural effusion; MPE: malignant pleural effusion; F: female; M: male; ADA: adenosine deaminase; LDH: lactate dehydrogenase; CEA: carcinoembryonic antigen; PE: pleural effusion; sMerTK: soluble form of Mer tyrosine kinase; IL-1β: interleukin 1 beta; TNF-α: tumor necrosis factor alpha; Used -test; #Used Chi-squared or Fisher’s exact test.